Examiner: BREDEFELD, RACHAEL EVA

Tech Center 3700 • Art Units: 1611 3786

This examiner grants 28% of resolved cases

Performance Statistics

27.5%

Allow Rate

-42.5% vs TC avg

537

Total Applications

+34.8%

Interview Lift

1664

Avg Prosecution Days

Based on 523 resolved cases, 2023–2026

1.5%

§101 Eligibility

13.3%

§102 Novelty

42.6%

§103 Obviousness

25.1%

§112 Clarity

App #	Title	Status	Assignee
18687962	METHODS AND COMPISITIONS FOR AMELIORATING BIOMARKERS ASSOCIATED WITH CARDIOVASCUALR RISK USING (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE	Final Rejection	AXSOME THERAPEUTICS, INC.
18487841	ESTER ANALOGS OF PSILOCIN, PROCESSES FOR THE PREPARATION THEREOF, AND METHODS OF USE	Final Rejection	Invyxis, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.